PTGS2 and breast cancer: The Western blot results showed that the protein expression levels of ACSL4, COX2 and NOX1 ferroptosis-inducing factors increased significantly after NGR1 treatment, while the protein expression levels of FIH1 and GPX4 ferroptosis inhibiting factors decreased significantly, suggesting that NGR1 was able to induce breast cancer cell ferroptosis.